Pegcetacoplan Beneficial for C3 Glomerulopathy, Immune-Complex MPGN

WEDNESDAY, Dec. 10, 2025-- Among patients with C3 glomerulopathy or primary immune-complex membranoproliferative glomerulonephritis (MPGN), pegcetacoplan, a C3 and C3b inhibitor, yields a significantly greater reduction in proteinuria than...